Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments: 2019-2024

Historic Change in Acquisitions & Divestments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $19.9 million.

  • Mirum Pharmaceuticals' Change in Acquisitions & Divestments rose 142.84% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year decrease of 23.68%. This contributed to the annual value of $19.9 million for FY2024, which is 87.00% down from last year.
  • Mirum Pharmaceuticals' Change in Acquisitions & Divestments amounted to $19.9 million in FY2024, which was down 87.00% from $153.0 million recorded in FY2023.
  • Mirum Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $155.6 million for FY2021, and its period low was $19.9 million during FY2024.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $140.3 million (2022), whereas its average is $104.4 million.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Change in Acquisitions & Divestments skyrocketed by 250.61% in 2020 and then crashed by 87.00% in 2024.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Change in Acquisitions & Divestments stood at $85.9 million in 2020, then soared by 81.14% to $155.6 million in 2021, then dropped by 9.83% to $140.3 million in 2022, then grew by 9.05% to $153.0 million in 2023, then slumped by 87.00% to $19.9 million in 2024.